GINA VANDEVENDER: Open Payments
NPI 1124039201 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 21 payments from 11 companies in 2025. Trend: 2023 $2,981 · 2024 $1,722 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $113 |
| Novo Nordisk Inc | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Cleerly, Inc. | 1 | $17 |
Products named: UBRELVY, QULIPTA, JARDIANCE, The Cologuard Plus Collection Kit, FARXIGA, Rybelsus, Auvelity, MOUNJARO.
Industry payments across TX — which companies pay providers there.
